Return to search results.
Complete title: A Phase 2, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Combined with nab-Paclitaxel Plus Gemcitabine Compared With nab-Paclitaxel Plus Gemcitabine in Subjects with Stage IV Previously Untreated Pancreatic Cancer (WIRB HALO-109-202)
|Research Study Number||2687.00|
|Principal Investigator||Sunil Hingorani, MD, PhD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Gastrointestinal Cancer; Pancreatic Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.